Aspergillosis
Researchers at the Morehouse School of Medicine have documented a case of invasive sphenoid sinus aspergillosis in a 75-year-old female patient with chronic neutropenia. The patient, who had treated mantle cell lymphoma, developed the rare infection despite not having classical or sustained immunosuppression. The diagnosis was confirmed through imaging and
Antifungal agents
Researchers from Otsuka Pharmaceutical Co., Ltd. and other institutions have conducted a study to identify a more effective diagnostic marker for invasive aspergillosis (IA), a life-threatening fungal infection. The study focused on galactosaminogalactan (GAG), a polysaccharide cell wall component secreted by Aspergillus hyphae. The researchers generated a monoclonal antibody against
Aspergillosis
Researchers at Gansu Provincial Hospital in Lanzhou, People's Republic of China have found that efficient diagnosis of patients at high risk for invasive aspergillosis (IA) can significantly improve the disease's outcome. The study, funded by the National Natural Science Foundation of China, aimed to assess the
